<html>
<head><!-- Global site tag (gtag.js) - Google Analytics -->
<script async src="https://www.googletagmanager.com/gtag/js?id=UA-158181022-1"></script>
<script>
  window.dataLayer = window.dataLayer || [];
  function gtag(){dataLayer.push(arguments);}
  gtag('js', new Date());

  gtag('config', 'UA-158181022-1');
</script>

<title>PAEDIATRIC UROLITHIASIS</title>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
<script language="JavaScript">
<!--
<!--
function MM_reloadPage(init) {  //reloads the window if Nav4 resized
  if (init==true) with (navigator) {if ((appName=="Netscape")&&(parseInt(appVersion)==4)) {
    document.MM_pgW=innerWidth; document.MM_pgH=innerHeight; onresize=MM_reloadPage; }}
  else if (innerWidth!=document.MM_pgW || innerHeight!=document.MM_pgH) location.reload();
}
MM_reloadPage(true);
// -->

function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_findObj(n, d) { //v4.0
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && document.getElementById) x=document.getElementById(n); return x;
}

function MM_nbGroup(event, grpName) { //v3.0
  var i,img,nbArr,args=MM_nbGroup.arguments;
  if (event == "init" && args.length > 2) {
    if ((img = MM_findObj(args[2])) != null && !img.MM_init) {
      img.MM_init = true; img.MM_up = args[3]; img.MM_dn = img.src;
      if ((nbArr = document[grpName]) == null) nbArr = document[grpName] = new Array();
      nbArr[nbArr.length] = img;
      for (i=4; i < args.length-1; i+=2) if ((img = MM_findObj(args[i])) != null) {
        if (!img.MM_up) img.MM_up = img.src;
        img.src = img.MM_dn = args[i+1];
        nbArr[nbArr.length] = img;
    } }
  } else if (event == "over") {
    document.MM_nbOver = nbArr = new Array();
    for (i=1; i < args.length-1; i+=3) if ((img = MM_findObj(args[i])) != null) {
      if (!img.MM_up) img.MM_up = img.src;
      img.src = (img.MM_dn && args[i+2]) ? args[i+2] : args[i+1];
      nbArr[nbArr.length] = img;
    }
  } else if (event == "out" ) {
    for (i=0; i < document.MM_nbOver.length; i++) {
      img = document.MM_nbOver[i]; img.src = (img.MM_dn) ? img.MM_dn : img.MM_up; }
  } else if (event == "down") {
    if ((nbArr = document[grpName]) != null)
      for (i=0; i < nbArr.length; i++) { img=nbArr[i]; img.src = img.MM_up; img.MM_dn = 0; }
    document[grpName] = nbArr = new Array();
    for (i=2; i < args.length-1; i+=2) if ((img = MM_findObj(args[i])) != null) {
      if (!img.MM_up) img.MM_up = img.src;
      img.src = img.MM_dn = args[i+1];
      nbArr[nbArr.length] = img;
  } }
}
//-->

</script>
<script type="text/javascript">

  var _gaq = _gaq || [];
  _gaq.push(['_setAccount', 'UA-17648363-4']);
  _gaq.push(['_trackPageview']);

  (function() {
    var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
    ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
  })();

</script>
<style type="text/css">
<!--
#apDiv1 {
	position:absolute;
	left:300px;
	top:400px;
	width:125px;
	height:50px;
	z-index:9;
}
-->
</style>
</head>

<body bgcolor="#FFFFFF" text="#000000" onLoad="MM_preloadImages('images/navigation/ndsbuttons/about.jpg','images/navigation/ndsbuttons/chiefed.jpg','images/navigation/ndsbuttons/seced.jpg','images/navigation/ndsbuttons/contributors.jpg','images/navigation/ndsbuttons/contents.jpg','images/navigation/ndsbuttons/sponsores.jpg','images/navigation/ndsbuttons/contact.jpg','images/navigation/ndsbuttons/button.jpg')">
<div id="banner" style="position:absolute; left:18px; top:12px; width:1558px; height:109px; z-index:1; background-color: #009999; layer-background-color: #009999; border: 1px none #000000"><img src="images/graphics/banner%20copy.jpg" width="1558" height="109"></div>
<div id="maintxt" style="position:absolute; left:284px; top:151px; width:1100px; height:236px; z-index:4; background-color: #33FFFF; layer-background-color: #33FFFF; border: 1px none #000000"> 
  <h1 align="center"><strong>PAEDIATRIC UROLITHIASIS</strong></h1>
  <h2 align="center">Prasad Godbole<br>Sheffield Children's NHS Foundation Trust, Sheffield, UK</h2>
  <p align="center" id="translator-p"><a href="https://v1.pediatricurologybook.com/es/libro/capitulo/8-39_urolitiasis_pediatrica.html">&rarr; Enlace a la versi&oacute;n en espa&ntilde;ol</a></p>
  <blockquote>&nbsp;</blockquote>
</div>
<div id="editors" style="position:absolute; left:302px; top:483px; width:998px; height:692px; z-index:5">
  <p><strong>Introduction:</strong></p>
  <p>Pediatric  urolithiasis is uncommon in western Europe with an incidence in the U.K. reported  to be less than 2/million population but much more frequently encountered in  the stone belt. In endemic urolithiasis, bladder calculi were much more  prevalent but with industrialisation, this incidence is decreasing. </p>
  <p><strong>Epidemiology:<br>
    </strong><br>
    Urinary  tract calculi are being recognised with increasing frequency&nbsp; with boys being affected more than girls.&nbsp; The vast majority of stones are seen in the  upper urinary tract . <br>
  <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
<!-- pedeatric -->
<ins class="adsbygoogle"
     style="display:inline-block;width:728px;height:90px"
     data-ad-client="ca-pub-3271938097114754"
     data-ad-slot="6645742649"></ins>
<script>
(adsbygoogle = window.adsbygoogle || []).push({});
</script></p>
  <p><strong>Pathophysiology</strong></p>
  <p>The  pathophysiology of stones is multifactorial and is determined by a combination  of urine flow and volume, crystal saturation and the urinary pH. Any factors  affecting these components may give rise to urinary tract stones (see Figure 1  below)</p>
  <p><img src="final_chapters/images/paedstone/risk.jpg" alt="fig1" width="633" height="395"></p>
  <p>Supersaturation  is the first prerequisite for stone formation. Crystallisation occurs due to  supersdaturation in association with an imbalance between promoters (increase)  and inhibitors (decrease). Promoters are mainly calcium, oxalate, phosphate and  urate. Inhibitors are citrate, ,pyrophosphate, glycosaminoglycans and  glycoproteins. Following supersaturation, crystals form in the lumen of the  tubules and may aggregate. If there are underlying metabolic disorders or  dietary causes, this may cause supersaturation. Poor diuresis may aggravate the  supersaturation. Urinary infection, most commonly due to urease producing  organisms cause alkalinisation of the urine and crystallisation/supersaturation  of several compounds such as struvite or carbapatite and ammonium urate.</p>
  <p>Stones  may be encountered early in the postnatal period in premature babies who have  been administered furosemide for their chronic lung disease. While not strictly  stones, this condition is known as nephrocalcinosis with crystals being  deposited in the medullary interstitium rather than the collecting system. </p>
  <p>&nbsp;</p>
  <p><strong>Diagnosis</strong>: The diagnosis of stones in children requires a high  index of suspicion as the presenting features may be varied. In any age group,  the symptoms may be those of a urinary tract infection with dysuria, frequency,  hematuria and passage of grit or small stones or matrix. This may be  accompanied by pain. In babies, stones may manifest themselves with lethargy, irritability,  poor feeding, pyrexia.</p>
  <p>The  confirmation of diagnosis rests on appropriate imaging. In children, the main  imaging modality is the renal ultrasound (US) along with a plain film KUB. The US is sensitive, specific and can  detect stones throughout the urinary tract. In the kidney, it can demonstrate  the location of the stones in the collecting system. However it is operator  dependent and may miss stones in the mid ureter or distal ureter especially if  obscured by bowel gas and if the bladder is empty. The plain KUB film is a useful adjunct to detect stones.  However faecal loading/bowel gas may obscure the view and hence the plain Xray  is not as sensitive as the US. <br>
    Other  imaging modalities can be used in those cases where there is a high index of suspicion  but no stone is visulaised by the combinationof an US and KUB.  In such cases a unenhanced spiral CT may demonstrate the presence of a stone.  Functional imaging prior to any intervention is important and the author  routinely performs a DMSA scan prior to any intervention. At the time of the  DMSA scan, it is worthwhile obtaining an IVU to demonstrate the calyceal  anatomy as this may affect the approach especially if a PCNL is being  considered.</p>
  <p><strong>Nature of stones</strong>: The nature and composition of stones can influence  the choice of technique and the success of the procedure. Cystine stones are  notoriously hard to disintegrate and the stones are faintly opaque. Struvite  stones usually have enough calcium phosphate incorporated to make them opaque.  Uric acid stones are radioluscent and calcium oxalate stones are the most  radioopaque.</p>
  <p><strong>Evaluation:</strong></p>
  <p>If  a stone is suspected, a full history including a dietary history should be  carried out. A family history of metabolic disorders or stones is important.  Any urological history that may predispose to stone formation such as a  augmentation cystoplasty should be addressed. Laboratory evaluation includes  urine bacteriology and biochemical analysis of blood and urine. Blood sampling  should include electrolytes ( including creatinine), calcium, phosphate and  uric acid. Urine analysis is usually performed on a 24 hour urine collection  although most labs can now perform the evaluation on a spot sample of urine.  Urine should be analysed for calcium, oxalate, uric acid, citrate and urinary  sodium and potassium. Calcium craetinine ration and oxalate creatinine ration  can be measured.<br>
    The  most important element of the evaluation is the analysis of the chemical  composition of the stone to determine etiology.</p>
  <p><strong>Non operative management&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></p>
  <p>In  children with stones, surgical removal with complete clearance of the stone  burden is the primary aim of intervention. The only indication for non  operative intervention would be following removal of a large stone with a  minute residual fragment which may be expected to pass spontaneously these are  sometimes called &lsquo;clinically insignificant residual fragments&rsquo;. Similarily, in  nephrocalcinosis or calcification in the interstitium, a watch and wait policy  may be implemented as in most cases, these calcific deposits may not progress  or in the the case of nephrocacinosis, may resolve. A small ureteric stone less  than 4mm in diameter can be watched in the absence of symptoms and proximal  dilatation in the anticipation of spontaneous passage. Medical management as is  in adult practice is for the use of alpha blockers such as tamsulosin (Flomax)  to relax the UVJ and thereby allowing the stone to pass.<br>
  <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
<!-- pedeatric -->
<ins class="adsbygoogle"
     style="display:inline-block;width:728px;height:90px"
     data-ad-client="ca-pub-3271938097114754"
     data-ad-slot="6645742649"></ins>
<script>
(adsbygoogle = window.adsbygoogle || []).push({});
</script></p>
  <p>&nbsp;</p>
  <p><strong>Operative management&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></p>
  <p><strong>Minimal access techniques: PCNL, ESWL,  URS, laparoscopy</strong></p>
  <p><strong>Open surgery: </strong>Open surgery is rarely indicated for paediatric  urolithiasis as the majority of the stones can be managed by minimally invasive  techniques either in isolation or in combination. In certain cases, open  surgery may be indicated for example in a UPJ obstruction with secondary stone  formation, but even in such situations, laparosocopy may be used with excellent  visualisation.</p>
  <p><strong>PCNL:</strong> Most of the experience in PCNL has been obtained from its use in  adults. However improvement in instrumentation and smaller size of instruments  has allowed this technique to be used in most children. PCNL can be used as  monotherapy or in conjunction with ESWL. </p>
  <p><strong>Indications </strong> </p>
  <ol start="1" type="1">
    <li>Large stone burden       e.g. staghorn calculus</li>
    <li>Single stone &gt; 2       cm in size</li>
    <li>Multiple stones</li>
  </ol>
  <p>Hard stone not amenable to disintegration by ESWL</p>
  <p><strong>Preoperative imaging</strong></p>
  <p>US  and Plain flm KUB: this allows  accurate localisation of the stone in the kidney and can help plan the  puncture. (figure 2a and b)</p>
  <p>IVU:  This demonstrates the calcyceal anatomy and the location of the stones within  the collecting system. Anatomical variations such as duplex systems or bifid  systems can also be detected preoperatively. </p>
  <p>DMSA:  through the same injection site at the same time as the IVU gives the function  of the kidney. Where the kidney is poorly functioning (&lt;10%), nephrectomy  may be the alternative and better intervention.</p>
  <p><strong>Technique: Video 1</strong></p>
  <ol start="1" type="1">
    <li>Preoperative       ureteric stenting via cystoscopy. The tip of the ureteric stent is placed       at the level of the UPJ. A Foley catheter is inserted and the stent       secured to the catheter to prevent displacement. A retrograde study is       then performed to visualise the anatomy ( Figure 3)</li>
    <li>The patient is       placed prone with the affected side at 30-45 degrees elevation. This       brings the posterior calyx end no to the direction of the puncture.</li>
    <li>Puncture: This can       be performed by US or fluoroscopic control based on the interventional       radiologists preference. We use a Kellett needle to puncture the lower       pole posterior calyx in most cases. Injection of saline with dilute methylene       blue through the retrograde catheter allows confirmation of puncture of       the collecting system.</li>
    <li>A J tipped guidewire       is placed via the puncture needle and ideally should go down the ureter.       If this is difficult, a hydrophilic guidewire (HiWire) can be used and       subsequently replaced with the J tipped guidewire. </li>
    <li>The tract is dilated       to the required size. The dilatation can be with a balloon dilator as in       adults. We prefer the use of serial metal (Alken) dilators as we believe       that they dilate the tract gradually rather than the sudden radial       dilatation with the balloon dilator. Positoin of the dilators is checked       with fluoroscopy. A 24 or 26F Amplatz sheath is then inserted over the       final dilator, its position confirmed by fluoroscopy and the dilators removed.       ( Figure 4)</li>
    <li>The stone is       visualised via the nephroscope and disintegrated either with an ultrasound       lithotripter, lithoclast or. Laser and the fragments retrieved with       grasping forceps.</li>
    <li>A second puncture       may be required at the same time or a separate session if complete       clearance cannot be obtained.</li>
    <li>An 8F&nbsp; nephrostomy is placed and the Amplatz       sheath is removed.</li>
    <li>The nephrostomy is       clamped 24 hours following the procedure and removed at 36 hours.</li>
  </ol>
  <p>&nbsp;</p>
  <p><strong>ESWL (Extracorporeal shock wave  lithotripsy)</strong></p>
  <p>Generation  of a shock wave by several techniques and the focusing of these waves no a  single point has been used in the management of stones for the last two  decades. The first ESWL was performed in Germany in 1980. The principle  behind the ESWL is threefold</p>
  <ol start="1" type="a">
    <li>generation of the       shock wave</li>
    <li>focusing of the       shock wave</li>
    <li>disintegration of       the stone</li>
  </ol>
  <p>&nbsp;</p>
  <ol start="1" type="a">
    <li>The shock wave can       be generated by one of three technique: </li>
  </ol>
  <ol start="1" type="1">
    <li>Electrohydraulic       (spark gap) lithotripter</li>
    <li>Piezoelectric       lithrotripter</li>
    <li>Electromagnetic       lithotripter</li>
  </ol>
  <p><strong>Electrohydraulic lithotripter:</strong></p>
  <p>This uses the spark gap  principle to generate the shock wave. Two electrodes are placed close together  and a high energy current passed between them. This creates a spark which  causes development of a shock wave in the surrounding water. This can be  focused on a target to disintegrate the stone. <br>
    The procedure requires that  the patient be submerged in a water bath and the equipment is bulky and  cumbersome. Furthermore the energy levels can fluctuate between shock waves. </p>
  <p>&nbsp;</p>
  <p><strong>Piezoelectric lithotripter</strong></p>
  <p>This uses piezoelectric  ceramic crystals arranged in a sphere which are charged and discharged to cause  creation of the shock wave. This can be focused on the target with a very high  level of accuracy. However the energy delivered is relatively small  necessitating longer treatment times and sometimes repeated procedures for  complete stone fragmentation.</p>
  <p><strong>Electromagnetic lithotripter</strong></p>
  <p>This uses two coils with  magnetic fields passed through them in opposite directions. These opposing  magnetic fields cause the laminar membrane adjacent to the coil to vibrate  thereby producing the shock wave. The wave can be focused through a concave  lens or via a cylindrical lens. The advantage of this system is that the  focusing adjuncts such as the ultrasound and the fluoroscopy unit are integral  to the shock wave generating device. This the most commonly used lithotripter.</p>
  <p><strong>Cavitation</strong></p>
  <p>The shock waves cause stone  disintegration by cavitation. This commences at the point of entry and creates  microbubbles by evaporation of the air within the stone. These microbubbles  collapse and coalesce with new microbubbles forming a secondary wave. This  process progresses through the entire stone till fragmentation occurs. This  process also occurs at the interface of the stone and adjacent tissue which may  lead to collateral injury.</p>
  <p>&nbsp;</p>
  <p><strong>Ureterorenoscopy (URS):  see video 2</strong></p>
  <p>The advent of smaller  ureteroscopes has made management of ureteric stones possible by minimal access  techniques. Several techniques of fragmenting the stones have been described  including Ho:YaG laser or lithoclast. Following preliminary retrogarade passage  of a guidewire, the uereteroscope is gently advanced into te uereteric orifice  and through the intramural portion of the uereter. In cases of an impacted stone,  insertion of a JJ stent for a few weeks may make this easier. The stone is  visulaised and may be stabilised with a basket (such as Nitinol basket). The  laser may then be used. It is important to ensure that the laser is in direct  contact on the surface of the stone prior to fragmentation. A basket cannot be  used if a small ureteroscope (4.5F) is used or if a lithoclast probe is used.<br>
    Larger fragments can be  retrieved following fragmentation using the basket but smaller fragments can be  left to pass spontaneously. Postoperative stenting for a week may be necessary  in case of large stones to enable the stones to pass. We do not routinely use  JJ stents following ureteroscopy and laser lithrotripsy.<br>
    The main complications of  this procedure are injury to the wall of the ureter and displacement of the  stone up to the kidney. </p>
  <p><strong>&nbsp;</strong></p>
  <p><strong>Laparoscopy</strong></p>
  <p>Laparoscopy can be used in  cases of a solitary renal pelvic stone, an impacted ureteric stone or stone in  an abnormally located kidney. The technique can be time consuming and is  dependent on the experience of the operator.</p>
  <p><strong>Complications&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></p>
  <p>PCNL<br>
    1. Failed puncture or inability to create tract<br>
    2. Sepsis<br>
    3. Bleeding requiring  transfusion<br>
    4. Injury or disruption of  collecting system<br>
    5. Residual calculi needing  further PCNL or ESWL<br>
    6. urinary leak/urinoma<br>
    7. conversion to open due to  significant bleeding</p>
  <p>ESWL</p>
  <ol start="1" type="1">
    <li>Bruising</li>
    <li>Ecchymosis</li>
    <li>Perirenal haemotoma</li>
    <li>Arrhytmias</li>
    <li>Lung injury if improper localistaion</li>
    <li>SteinStrasse- due to large stone burden </li>
    <li>clot colic</li>
    <li>pain and inability to tolerate ESWL without a       general anaesthetic. In our unit, ESWL is offered to children above 12       years of age without an anaesthetic. All other children require a general       anaesthetic for the procedure.</li>
  </ol>
  <p>&nbsp;</p>
  <p>URS</p>
  <ol start="1" type="1">
    <li>Injury/disruption of ureter</li>
    <li>urosepsis</li>
    <li>urinary leak</li>
    <li>residual calculus</li>
    <li>bleeding</li>
    <li>pain</li>
  </ol>
  <p>Long  term outcome</p>
  <p><strong>Short and Long term outcomes&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></p>
  <p>&nbsp;The main outcome measures of any surgical  intervention for pediatric urolithiasis include</p>
  <p>Stone  clearance<br>
    Morbidity<br>
    Renal  injury long term<br>
    Recurrence</p>
  <p>ESWL</p>
  <p>The  theoretical long term safety and biological effects of ESWL on renal function  and growth are debatable.&nbsp; Brinkman et al  noted no evidence of renal scarring, changes in blod pressure or loss of renal  function in their series of 63 children undergoing ESWL. GFR may decrease following ESWL but returns to  normal within 3 months. The radiation exposure during ESWL is comparable to  other diagnostic radiographic procedures. </p>
  <p>Depending  on the nature of the stone, position of the stone and calyceal anatomy, stone  clearance rates vary between 75-80% in various series.&nbsp; Mulitiple sessions may be required to obtain  a higher clearance. Stenting is not usually required in children. Where there  is a high stone burden, stone clearance rates vary between 33-80% . The short  term morbidity is described above. Stone free rates vary between 75-100% for  ureteral stones depending on inability to localise the stone.</p>
  <p>PCNL</p>
  <p>Studies  demonstrate minimal scarring and insignificant loss of renal function after  renal function after PCNL. Intraoperative haemorrhage is related to the number  of tracts and calibre of the tract. Multiple tracts may increase blood loss but  are not related to increased risk of complications.</p>
  <p>Clearance  rates with PCNL as monotherapy or as part of sandwich therapy achieve a clearance  rates of between 85-96%. </p>
  <p>URS</p>
  <p>Ureteral  dilatation does not increase the risk of stricture and significant  vesicoureteral reflux following ureteroscopy. The incidence of low grade VUR  can be as high as 15% after ureteroscopic procedures. <br>
  <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
<!-- pedeatric -->
<ins class="adsbygoogle"
     style="display:inline-block;width:728px;height:90px"
     data-ad-client="ca-pub-3271938097114754"
     data-ad-slot="6645742649"></ins>
<script>
(adsbygoogle = window.adsbygoogle || []).push({});
</script></p>
  <p>&nbsp;</p>
  <p><strong>Suggested further reading</strong></p>
  <pre>1: Badawy AA, Saleem MD, Abolyosr A, Aldahshoury M, Elbadry MS, Abdalla MA,</pre>
  <pre>Abuzeid AM. Extracorporeal shock wave lithotripsy as first line treatment for</pre>
  <pre>urinary tract stones in children: outcome of 500 cases. Int Urol Nephrol. 2012</pre>
  <pre>&nbsp;</pre>
  <pre>&nbsp;</pre>
  <pre>2: Ba&#351;tu&#287; F, D&uuml;&#351;&uuml;nsel R. Pediatric urolithiasis: causative factors, diagnosis and</pre>
  <pre>medical management. Nat Rev Urol. 2012 Feb 7. </pre>
  <pre>&nbsp;</pre>
  <pre>&nbsp;</pre>
  <pre>3: Ba&#351;tu&#287; F, G&uuml;nd&uuml;z Z, T&uuml;lpar S, Poyrazo&#287;lu H, D&uuml;&#351;&uuml;nsel R. Urolithiasis in</pre>
  <pre>infants: evaluation of risk factors. World J Urol. 2012 Jan 19. [Epub ahead of</pre>
  <pre>print.</pre>
  <pre>&nbsp;</pre>
  <pre>&nbsp;</pre>
  <pre>4: Desai M. Treatment of pediatric urolithiasis: how small is &quot;small enough&quot;?</pre>
  <pre>World J Urol. 2011 ;29(6):705-6</pre>
  <pre>&nbsp;</pre>
  <pre>&nbsp;</pre>
  <pre>5: Goktas C, Akca O, Horuz R, Gokhan O, Albayrak S, Sarica K. SWL in lower</pre>
  <pre>calyceal calculi: evaluation of the treatment results in children and adults.</pre>
  <pre>Urology. 2011 Dec;78(6):1402-6.</pre>
  <pre>&nbsp;</pre>
  <pre>6: Habbig S, Beck BB, Hoppe B. Nephrocalcinosis and urolithiasis in children.</pre>
  <pre>Kidney Int. 2011 Dec;80(12):1278-91.</pre>
  <pre>&nbsp;</pre>
  <pre>&nbsp;</pre>
  <pre>7: Dogan HS, Onal B, Satar N, Aygun C, Piskin M, Tanriverdi O, Gurocak S, Gunay</pre>
  <pre>LM, Burgu B, Ozden E, Nazli O, Erdem E, Yucel S, Kefi A, Demirci D, Uluocak N,</pre>
  <pre>Aridogan IA, Turunc T, Yalcin V, Kilinc M, Horasanli K, Tan MO, Soygur T,</pre>
  <pre>Sarikaya S, Kilicarslan H, Turna B, Doruk HE, Tekgul S. Factors affecting</pre>
  <pre>complication rates of ureteroscopic lithotripsy in children: results of</pre>
  <pre>multi-institutional retrospective analysis by Pediatric Stone Disease Study Group</pre>
  <pre>of Turkish Pediatric Urology Society. J Urol. 2011 Sep;186(3):1035-40. </pre>
  <pre>&nbsp;</pre>
  <pre>&nbsp;</pre>
  <pre>8: Sas DJ. An update on the changing epidemiology and metabolic risk factors in</pre>
  <pre>pediatric kidney stone disease. Clin J Am Soc Nephrol. 2011 Aug;6(8):2062-8. </pre>
  <pre>&nbsp;</pre>
  <pre>&nbsp;</pre>
  <pre>9: Schissel BL, Johnson BK. Renal stones: evolving epidemiology and management.</pre>
  <pre>Pediatr Emerg Care. 2011 Jul;27(7):676-81.</pre>
  <pre>&nbsp;</pre>
  <pre>&nbsp;</pre>
  <pre>10: Chang HY, Hsu CH, Tsai JD, Li ST, Hung HY, Kao HA, Chang JH, Chung HY, Wang</pre>
  <pre>HK. Renal calcification in very low birth weight infants. Pediatr Neonatol. 2011 </pre>
  <pre>Jun;52(3):145-9. </pre>
  <pre>&nbsp;</pre>
  <pre>11: Polito C, Apicella A, Marte A, Signoriello G, La Manna A. Clinical</pre>
  <pre>presentation and metabolic features of overt and occult urolithiasis. Pediatr</pre>
  <pre>Nephrol. 2012 Jan;27(1):101-7..</pre>
  <pre>&nbsp;</pre>
  <pre>&nbsp;</pre>
  <pre>12: Desai MR, Sharma R, Mishra S, Sabnis RB, Stief C, Bader M. Single-step</pre>
  <pre>percutaneous nephrolithotomy (microperc): the initial clinical report. J Urol.</pre>
  <pre>2011 Jul;186(1):140-5..</pre>
  <pre>&nbsp;</pre>
  <pre>&nbsp;</pre>
  <pre>13: Kumar R, Anand A, Saxena V, Seth A, Dogra PN, Gupta NP. Safety and efficacy</pre>
  <pre>of PCNL for management of staghorn calculi in pediatric patients. J Pediatr Urol.</pre>
  <pre>2011 Jun;7(3):248-51. </pre>
  <pre>&nbsp;</pre>
  <pre>14: Panfeng S, Hong C, Zhongjin Y, Wei Z, Wenhui L, Baoguang S, Junsheng B,</pre>
  <pre>Liingjun Z, Zizhen H. Management of pediatric urolithiasis induced by</pre>
  <pre>melamine-contaminated powdered formula (report of 619 cases). Urology. 2011</pre>
  <pre>Aug;78(2):411-6. </pre>
  <pre>&nbsp;</pre>
  <pre>15: Mishra S, Sharma R, Garg C, Kurien A, Sabnis R, Desai M. Prospective</pre>
  <pre>comparative study of miniperc and standard PNL for treatment of 1 to 2 cm size</pre>
  <pre>renal stone. BJU Int. 2011 Sep;108(6):896-9; discussion 899-900. doi:</pre>
  <pre>10.1111/j.1464-410X.2010.09936.x. </pre>
  <pre>&nbsp;</pre>
  <pre>16: Raju GA, Norris RD, Ost MC. Endoscopic stone management in children. Curr</pre>
  <pre>Opin Urol. 2010 Jul;20(4):309-12..</pre>
  <pre>&nbsp;</pre>
  <pre>&nbsp;</pre>
  <pre>17: Dillman JR, Kappil M, Weadock WJ, Rubin JM, Platt JF, DiPietro MA, Bude RO.</pre>
  <pre>Sonographic twinkling artifact for renal calculus detection: correlation with CT.</pre>
  <pre>Radiology. 2011 Jun;259(3):911-6..</pre>
  <pre>&nbsp;</pre>
  <pre>&nbsp;</pre>
  <pre>18: Rizvi SA, Sultan S, Ijaz H, Mirza ZN, Ahmed B, Saulat S, Umar SA, Naqvi SA.</pre>
  <pre>Open surgical management of pediatric urolithiasis: A developing country</pre>
  <pre>perspective. Indian J Urol. 2010 Oct;26(4):573-6. </pre>
  <pre>&nbsp;</pre>
  <pre>&nbsp;</pre>
  <pre>19: Reddy PP, Defoor WR. Ureteroscopy: The standard of care in the management of </pre>
  <pre>upper tract urolithiasis in children. Indian J Urol. 2010 Oct;26(4):555-63.</pre>
  <pre>&nbsp;</pre>
  <pre>20: Ganpule AP, Mishra S, Desai MR. Percutaneous nephrolithotomy for pediatric</pre>
  <pre>urolithiasis. Indian J Urol. 2010 Oct;26(4):549-54. </pre>
  <pre>&nbsp;</pre>
  <pre>&nbsp;</pre>
  <pre>21: Zhu J, Phillips TM, Mathews RI. Operative management of pediatric</pre>
  <pre>urolithiasis. Indian J Urol. 2010 Oct;26(4):536-43. </pre>
  <pre>&nbsp;</pre>
  <pre>&nbsp;</pre>
  <pre>22: Sharma AP, Filler G. Epidemiology of pediatric urolithiasis. Indian J Urol.</pre>
  <pre>2010 Oct;26(4):516-22. </pre>
  <pre>&nbsp;</pre>
  <pre>23: Ansari MS. Pediatric urolithiasis: A challenging problem. Indian J Urol. 2010</pre>
  <pre>Oct;26(4):515. </pre>
  <pre>&nbsp;</pre>
  <pre>24: Cortes JA, Motamedinia P, Gupta M. Update on technological and selection</pre>
  <pre>factors influencing shockwave lithotripsy of renal stones in adults and children.</pre>
  <pre>Curr Opin Urol. 2011 Mar;21(2):134-40..</pre>
  <pre>&nbsp;</pre>
  <pre>&nbsp;</pre>
  <pre>25: Hwang K, Mason MD, Peters CA. Clinical practice: surgical approaches to</pre>
  <pre>urolithiasis in children. Eur J Pediatr. 2011 Jun;170(6):681-8. </pre>
  <pre>&nbsp;</pre>
  <pre>&nbsp;</pre>
  <pre>26: Matlaga BR, Schaeffer AJ, Novak TE, Trock BJ. Epidemiologic insights into</pre>
  <pre>pediatric kidney stone disease. Urol Res. 2010 Dec;38(6):453-7. </pre>
  <pre>&nbsp;</pre>
  <pre>&nbsp;</pre>
  <pre>27: Porowski T, Kirejczyk JK, Zoch-Zwierz W, Konstantynowicz J,</pre>
  <pre>Korzeniecka-Kozerska A, Motkowski R, Laube N. Assessment of lithogenic risk in</pre>
  <pre>children based on a morning spot urine sample. J Urol. 2010 Nov;184(5):2103-8.</pre>
  <pre>.</pre>
  <pre>&nbsp;</pre>
  <pre>&nbsp;</pre>
  <pre>28: DiSandro M. Pediatric urolithiasis: children as little adults. J Urol. 2010</pre>
  <pre>Nov;184(5):1833-4. </pre>
  <pre>&nbsp;</pre>
  <pre>29: Kieran K, Giel DW, Morris BJ, Wan JY, Tidwell CD, Giem A, Jerkins GR,</pre>
  <pre>Williams MA. Pediatric urolithiasis--does body mass index influence stone</pre>
  <pre>presentation and treatment? J Urol. 2010 Oct;184(4 Suppl):1810-5. </pre>
  <pre>&nbsp;</pre>
  <pre>&nbsp;</pre>
  <pre>30: Routh JC, Graham DA, Nelson CP. Trends in imaging and surgical management of </pre>
  <pre>pediatric urolithiasis at American pediatric hospitals. J Urol. 2010 Oct;184(4</pre>
  <pre>Suppl):1816-22. </pre>
  <pre>&nbsp;</pre>
  <pre>31: Ozkan KU, Bakan V, Mil A, Ozturk S. Ureteroscopic stone management in</pre>
  <pre>prepubertal children. Urol Int. 2010;85(3):320-3. </pre>
  <pre>&nbsp;</pre>
  <pre>&nbsp;</pre>
  <pre>32: Routh JC, Graham DA, Nelson CP. Epidemiological trends in pediatric</pre>
  <pre>urolithiasis at United States freestanding pediatric hospitals. J Urol. 2010</pre>
  <pre>Sep;184(3):1100-4. </pre>
  <pre>&nbsp;</pre>
  <pre>&nbsp;</pre>
  <pre>33: Nelson CP. Extracorporeal shock wave lithotripsy in the pediatric population.</pre>
  <pre>Urol Res. 2010 Aug;38(4):327-31..</pre>
  <pre>&nbsp;</pre>
  <pre>&nbsp;</pre>
  <pre>34: Thomas JC. How effective is ureteroscopy in the treatment of pediatric stone </pre>
  <pre>disease? Urol Res. 2010 Aug;38(4):333-5. </pre>
  <pre>&nbsp;</pre>
  <pre>35: Alaya A, Najjar MF, Nouri A. Pediatric urolithiasis in the central coast of</pre>
  <pre>Tunisia: Epidemiologic changes over the past twenty-five years. Saudi J Kidney</pre>
  <pre>Dis Transpl. 2010 Jul;21(4):762-71. </pre>
  <pre>&nbsp;</pre>
  <pre>36: Tanriverdi O, Silay MS, Kendirci M, Kadihasanoglu M, Aydin M, Horasanli K,</pre>
  <pre>Miroglu C. Comparison of ureteroscopic procedures with rigid and semirigid</pre>
  <pre>ureteroscopes in pediatric population: does the caliber of instrument matter?</pre>
  <pre>Pediatr Surg Int. 2010 Jul;26(7):733-8..</pre>
  <pre>&nbsp;</pre>
  <pre>&nbsp;</pre>
  <pre>37: Cerwinka WH, Kirsch AJ. Magnetic resonance urography in pediatric urology.</pre>
  <pre>Curr Opin Urol. 2010 Jul;20(4):323-9. </pre>
  <pre>&nbsp;</pre>
  <pre>38: Sas DJ, Hulsey TC, Shatat IF, Orak JK. Increasing incidence of kidney stones </pre>
  <pre>in children evaluated in the emergency department. J Pediatr. 2010</pre>
  <pre>Jul;157(1):132-7. </pre>
  <pre>&nbsp;</pre>
  <pre>39: DeFoor WR, Jackson E, Minevich E, Caillat A, Reddy P, Sheldon C, Asplin J.</pre>
  <pre>The risk of recurrent urolithiasis in children is dependent on urinary calcium</pre>
  <pre>and citrate. Urology. 2010 Jul;76(1):242-5. </pre>
  <pre>&nbsp;</pre>
  <pre>&nbsp;</pre>
  <pre>40: Unsal A, Resorlu B, Kara C, Bozkurt OF, Ozyuvali E. Safety and efficacy of</pre>
  <pre>percutaneous nephrolithotomy in infants, preschool age, and older children with</pre>
  <pre>different sizes of instruments. Urology. 2010 Jul;76(1):247-52. </pre>
  <pre>&nbsp;</pre>
  <pre>&nbsp;</pre>
  <pre>41: Aydogdu O, Burgu B, Gucuk A, Suer E, Soygur T. Effectiveness of doxazosin in </pre>
  <pre>treatment of distal ureteral stones in children. J Urol. 2009 Dec;182(6):2880-4. </pre>
  <pre>&nbsp;</pre>
  <pre>&nbsp;</pre>
  <pre>42: Passerotti C, Chow JS, Silva A, Schoettler CL, Rosoklija I, Perez-Rossello J,</pre>
  <pre>Cendron M, Cilento BG, Lee RS, Nelson CP, Estrada CR, Bauer SB, Borer JG, Diamond</pre>
  <pre>DA, Retik AB, Nguyen HT. Ultrasound versus computerized tomography for evaluating</pre>
  <pre>urolithiasis. J Urol. 2009 Oct;182(4 Suppl):1829-34. </pre>
  <pre>&nbsp;</pre>
  <pre>&nbsp;</pre>
  <pre>43: Riccabona M, Avni FE, Blickman JG, Dacher JN, Darge K, Lobo ML, Willi U.</pre>
  <pre>Imaging recommendations in paediatric uroradiology. Minutes of the ESPR</pre>
  <pre>uroradiology task force session on childhood obstructive uropathy, high-grade</pre>
  <pre>fetal hydronephrosis, childhood haematuria, and urolithiasis in childhood. ESPR</pre>
  <p>Annual  Congress, Edinburgh, UK, June 2008. Pediatr Radiol. 2009  Aug;39(8):891-8.</p>
  <p><strong>Legends</strong></p>
  <p>Figure  1: Risk factor model for calcium and uric acid stone production</p>
  <p>Figure  2a and b. Plain Xray KUB showing  multiple stones in the Right kidney in a boy with cystinuria. &nbsp;Ultrasound showing multiple stones within the  kidney amenable to PCNL</p>
  <p>Figure  3. Retrograde demonstrating stones predominantly in the lower pole allowing  puncture of the appropriate calyx</p>
  <p>Figure  4. Image showing guidewire down the right ureter, amplatz sheath in position  and metal dilators being removed</p>
  <p>Video  1. Video of PCNL using the Storz calcuson ultrasonic lithotripter</p>
  <p>Video  2. Video of URS for impacted  ureteric stone</p>
  <p>&nbsp;</p>
  <p><strong>Editorial Comment:</strong></p>
  <p>The  management of paediatric stones has come a long way over the last two decades.  Improvements in technology have played a major part in this development. For  such a service to be successful, it requires a dedicated specialist prepared to  lead the multidisciplinary team. Furthermore, these procedures take time  especially during the learning curve and the entire team should be prepared for  this.</p>
  <p>In  terms of technology, the previous 24 or 26 Amplatz sheaths could be difficult  and possibly traumatic to infant kidneys. The advent of the mini perc kit with  sheaths as small as 11 Fr and a mini nephroscope has allowed this to be used in  small children. This technique however necessitates the use of laser which in  cases of a large stone burden can take a long time to clear. </p>
  <p>It  goes without saying that such a service cannot be set up and be successful  without having all the required equipment including adjuncts. In our service,  we have the adult and mini perc kits including nephroscopes; flexible and semi  rigid ureteroscope, flexible cystoscope, laser, swiss lithoclast, a selection  of guide wires ( including hydrophilic), a cobra (vascular) catheter and a  range of baskets, graspers etc. nothing can be more frustrating then being able  to visulaise the stone but unable to retrieve it due to awkward anatomy and  lack of the appropriate instrument.</p>
  <p>Figure  2a<br>
    <img src="paediatric_urolithiasis_clip_image002.jpg" alt="img2" width="364" height="372"></p>
  <p>&nbsp;</p>
  <p>Figure  2b<br>
      <img src="paediatric_urolithiasis_clip_image004.jpg" alt="img4" width="480" height="312"></p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>Figure  3</p>
  <p>&nbsp;</p>
  <p><img src="paediatric_urolithiasis_clip_image006.jpg" alt="img6" width="353" height="353"></p>
  <p>&nbsp;</p>
  <p>Figure  4</p>
  <p>&nbsp;</p>
  <p><img src="paediatric_urolithiasis_clip_image008.jpg" alt="img8" width="366" height="366"></p>
  <p>&nbsp;  </p>
  <p>&nbsp;  </p>
  <p><br>
  </p>
  <p>&nbsp;</p>
</div>
<div id="Layer1" style="position:absolute; left:624px; top:436px; width:400; height:40; z-index:6"></div>
<div id="Layer2" style="position:absolute; left:19px; top:151px; width:250; height:250; z-index:7"><img src="images/graphics/logo004.jpg" width="250" height="250"></div>
<div id="Layer3" style="position:absolute; left:41px; top:459px; width:203px; height:713px; z-index:8"> 
  <table border="0" cellpadding="0" cellspacing="0">
    <tr>
      <td><a href="about.htm" onClick="MM_nbGroup('down','group1','about','images/navigation/ndsbuttons/about.jpg',1)" onMouseOver="MM_nbGroup('over','about','images/navigation/ndsbuttons/about.jpg','images/navigation/ndsbuttons/about.jpg',1)" onMouseOut="MM_nbGroup('out')"><img name="about" src="images/navigation/ndsbuttons/about.jpg" border="0" onLoad="" width="200" height="80"></a></td>
    </tr>
    <tr>
      <td><a href="chiefeditors.htm" onClick="MM_nbGroup('down','group1','chiefed','images/navigation/ndsbuttons/chiefed.jpg',1)" onMouseOver="MM_nbGroup('over','chiefed','images/navigation/ndsbuttons/chiefed.jpg','images/navigation/ndsbuttons/chiefed.jpg',1)" onMouseOut="MM_nbGroup('out')"><img name="chiefed" src="images/navigation/ndsbuttons/chiefed.jpg" border="0" onLoad="" width="200" height="80"></a></td>
    </tr>
    <tr>
      <td><a href="sectioneditors.htm" onClick="MM_nbGroup('down','group1','sected','images/navigation/ndsbuttons/seced.jpg',1)" onMouseOver="MM_nbGroup('over','sected','images/navigation/ndsbuttons/seced.jpg','images/navigation/ndsbuttons/seced.jpg',1)" onMouseOut="MM_nbGroup('out')"><img name="sected" src="images/navigation/ndsbuttons/seced.jpg" border="0" onLoad="" width="200" height="80"></a></td>
    </tr>
    <tr>
      <td><a href="contributors.htm" onClick="MM_nbGroup('down','group1','contribu','images/navigation/ndsbuttons/contributors.jpg',1)" onMouseOver="MM_nbGroup('over','contribu','images/navigation/ndsbuttons/contributors.jpg','images/navigation/ndsbuttons/contributors.jpg',1)" onMouseOut="MM_nbGroup('out')"><img name="contribu" src="images/navigation/ndsbuttons/contributors.jpg" border="0" onLoad="" width="200" height="80"></a></td>
    </tr>
    <tr>
      <td><a href="contents.htm" onClick="MM_nbGroup('down','group1','contents','images/navigation/ndsbuttons/contents.jpg',1)" onMouseOver="MM_nbGroup('over','contents','images/navigation/ndsbuttons/contents.jpg','images/navigation/ndsbuttons/contents.jpg',1)" onMouseOut="MM_nbGroup('out')"><img name="contents" src="images/navigation/ndsbuttons/contents.jpg" border="0" onLoad="" width="200" height="80"></a></td>
    </tr>
    <tr>
      <td><a href="links.htm" onClick="MM_nbGroup('down','group1','sponsors','images/navigation/ndsbuttons/sponsores.jpg',1)" onMouseOver="MM_nbGroup('over','sponsors','images/navigation/ndsbuttons/sponsores.jpg','images/navigation/ndsbuttons/sponsores.jpg',1)" onMouseOut="MM_nbGroup('out')"><img name="sponsors" src="images/navigation/ndsbuttons/sponsores.jpg" border="0" onLoad="" width="200" height="80"></a></td>
    </tr>
    <tr>
      <td><a href="contact.htm" onClick="MM_nbGroup('down','group1','contact','images/navigation/ndsbuttons/contact.jpg',1)" onMouseOver="MM_nbGroup('over','contact','images/navigation/ndsbuttons/contact.jpg','images/navigation/ndsbuttons/contact.jpg',1)" onMouseOut="MM_nbGroup('out')"><img name="contact" src="images/navigation/ndsbuttons/contact.jpg" border="0" onLoad="" width="200" height="80"></a></td>
    </tr>
    <tr>
      <td><a href="index.htm" onClick="MM_nbGroup('down','group1','home','images/navigation/ndsbuttons/button.jpg',1)" onMouseOver="MM_nbGroup('over','home','images/navigation/ndsbuttons/button.jpg','images/navigation/ndsbuttons/button.jpg',1)" onMouseOut="MM_nbGroup('out')"><img name="home" src="images/navigation/ndsbuttons/button.jpg" border="0" onLoad="" width="200" height="80"></a></td>
    </tr>
  </table>
</div>
<div id="apDiv1"><style type="text/css">
@import url(//www.google.com/cse/api/branding.css);
</style>
<div class="cse-branding-bottom" style="background-color:#FFFFFF;color:#000000">
  <div class="cse-branding-form">
    <form action="http://www.google.com" id="cse-search-box">
      <div>
        <input type="hidden" name="cx" value="partner-pub-3271938097114754:5029408643" />
        <input type="hidden" name="ie" value="UTF-8" />
        <input type="text" name="q" size="30" />
        <input type="submit" name="sa" value="Search" />
      </div>
    </form>
  </div>
  <div class="cse-branding-logo">
    <img src="http://www.google.com/images/poweredby_transparent/poweredby_FFFFFF.gif" alt="Google" />
  </div>
  <div class="cse-branding-text">
    Custom Search
  </div>
</div>
</div>
</body>
</html>
